From: A robust fuzzy rule based integrative feature selection strategy for gene expression data in TCGA
Cancer Type | Selected gene signatures |
---|---|
BRCA | ABCB5, ADAMTS5, ALX4, ANPEP, APCDD1, ARHGAP20, BCHE, BRCA2, CCL11, CCL28, CDKN2A, CEBPA, CHRNA6, CNN1, COL6A6, CX3CL1, DNAH14, EMILIN2, ERBB2, FGF10, GRID1, GSN, HTR2A, KCNJ2, KCNMB1, KLB, KRT4, LEP, LOXL1, LRIT2, MYOC, NRN1, OLFM3, OR10A3, OXTR, P4HA3, PENK, PRSS55, PSG3, RAX2, RPE65, SH3TC2, TBX15, TPO, VGLL2, WISP1, WT1 |
PRAD | AMDHD1, AMY2B, AQP5, C17orf102, C19orf45, CHST4, GABRR1, GCKR, HSD17B3, IL17A, LTK, OVCH2, PTCHD3, PTGS2, RPL10L, SEPT12, SOX8, TRH, TYR, UGT2B10, UGT3A1, VSIG10L, ZNHIT2 |
LIHC | ADCYAP1R1, AMPD1, ANKRD34A, ANKRD34C, B3GALT5, B4GALNT1, C1orf177, CASQ2, CCL19, CD207, CDH13, CDKN2A, CSPG4, DMC1, EBF2, ECM1, ELAVL2, EPO, FHL5, GJA1, GJC1, GLYATL2, GOLGA8A, GYPA, HBB, HBD, HSF4, HSPG2, IFITM4P, IL20RA, IL20RB, IRX3, LCE2D, MARCH4, MKRN3, NPAS4, NRXN1, OR51E2, PCSK2, PDZD2, PKMYT1, PMP2, RBM11, SEMA5B, SFTA1P, SLC17A8, SLCO1C1, STC2, TAC1, TM4SF18 |
HNSC | ALG1L, BOC, CA13, CLDN10, CMA1, CNTFR, DIXDC1, FGFR2, FOXS1, GBX2, GPT, HCN1, HOXC6, HOXC9, HOXD10, HOXD9, HPR, KALRN, KIR2DS4, LAIR2, LPPR5, MARCH4, MMP13, PAEP, PCDHGA9, PCDHGB7, PCK1, PHGDH, PIK3R1, PTCHD3, RIMS4, SCIN, SDPR, SLC46A2, SLC5A8, SORBS2, SOX11, SPP1, SRD5A2, SVIP, TAC1, TGFBR3, TMEM132C, TMEM217, TRPC4, ZIC5, ZNF132, ZNF43, ZNF486, ZNF608, ZNF626, ZNF677, ZNF813, ZNF844 |
KIRP | ABCA4, AFAP1L2, ALDOB, ASPG, B3GALT2, BIRC5, C17orf78, CA9, CCNI2, CDKN2A, CHP2, CLDN19, ENOX1, FOXD2, GINS2, GREM2, INSRR, KIFC2, KNG1, MET, MUC15, MYOM1, NOTUM, PLIN2, PTCHD3, SFRP1, SIAH3, SPRR2A, ST6GALNAC3, VEGFA |
THCA | APOD, CDKL2, CLEC4F, CSF2, HAPLN1, ITIH2, KLHDC8A, KLK13, MMP23A, MYOC, R3HDML, RBP4 |